Statistical Analysis of Influenza Vaccine Lot Consistency Studies
Author:
- 1 August 2006
- journal article
- research article
- Published by Taylor & Francis in Journal of Biopharmaceutical Statistics
- Vol. 16 (4) , 443-452
Abstract
This paper presents an integrated statistical approach to the analysis of influenza vaccine lot consistency studies in which three lots are compared. The approach ensures that the overall Type I error rate (i.e., the probability of wrongly concluding that the lots are similar) is controlled. It is argued that the optimum efficacy measure is the geometric mean titer. The approach is demonstrated using data from a randomized, double-blind lot consistency study in which three consecutive production lots of Solvay Pharmaceutical' new, virosomal subunit influenza vaccine Invivac ® were compared.Keywords
This publication has 9 references indexed in Scilit:
- Lot Consistency as an Equivalence ProblemJournal of Biopharmaceutical Statistics, 2004
- Seroprotection rate, mean fold increase, seroconversion rate: which parameter adequately expresses seroresponse to influenza vaccination?Virus Research, 2004
- Safety and immunogenicity of a live-attenuated influenza vaccine blended and filled at two manufacturing facilitiesVaccine, 2003
- Choosing an equivalence limit for noninferiority or equivalence studiesControlled Clinical Trials, 2002
- Prospective, randomized, placebo-controlled evaluation of the safety and immunogenicity of three lots of intranasal trivalent influenza vaccine among young childrenThe Pediatric Infectious Disease Journal, 2001
- Design and Analysis of Three Treatment Equivalence TrialsControlled Clinical Trials, 2000
- ON TESTING EQUIVALENCE OF THREE POPULATIONSJournal of Biopharmaceutical Statistics, 1999
- Bioequivalence trials, intersection-union tests and equivalence confidence setsStatistical Science, 1996
- A comparison of the Two One-Sided Tests Procedure and the Power Approach for assessing the equivalence of average bioavailabilityJournal of Pharmacokinetics and Biopharmaceutics, 1987